Nurse-coordinated care in CKD: Time for translation into practice?

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 6, 2011, Pages 1229-1231

  Smith, David H ^a   Thorp, Micah L ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; EDITORIAL; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; KIDNEY FUNCTION; NURSING CARE; PATIENT CARE; PATIENT SATISFACTION; PRACTICE GUIDELINE; QUALITY OF LIFE;

BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COST-BENEFIT ANALYSIS; CREATININE; DISEASE PROGRESSION; GENERAL PRACTICE; GLOMERULAR FILTRATION RATE; HEALTH CARE COSTS; HEMATINICS; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; KIDNEY; KIDNEY DISEASES; NURSE CLINICIANS; PATIENT CARE TEAM; PLATELET AGGREGATION INHIBITORS; PREVENTIVE HEALTH SERVICES; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEVERITY OF ILLNESS INDEX; SMOKING CESSATION; TREATMENT OUTCOME; UP-REGULATION;

EID: 79958201889     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03620411     Document Type: Editorial

References (20)

1. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
2. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van LF, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
3. K/DOQI: K/DOQI clinical practice guidelines for chronic kid-ney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S266, 2002
4. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663, 2004
5. Smith DH, Gullion CM, Nichols G, Keith DS, Brown JB: Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population. J Am Soc Nephrol 15: 1300-1306, 2004
6. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F, Lameire N: Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 20: 1048-1056, 2005
7. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, Burns K, Manns B, White C, Madore F, Moist L, Klarenbach S, Barrett B, Foley R, Jindal K, Senior P, Pannu N, Shurraw S, Akbari A, Cohn A, Reslerova M, Deved V, Mendelssohn D, Nesrallah G, Kappel J, Tonelli M, for the Canadian Society of Nephrology: Guidelines for the management of chronic kidney disease. CMAJ 179: 1154-1162, 2008
8. National Institute for Health and Clinical Excellence (NICE). Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care. National Collaborating Center for Chronic Conditions, London, Royal College of Physicians, 2010
9. Bayliss EA, Bhardwaja B, Ross C, Beck A, Lanese DM: Multidisciplinary team care may slow the rate of decline in renal function. Clin J Am Soc Nephrol 6: 704-710, 2011
10. Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L: Systematic review of multidisciplinary interventions in heart failure. Heart 91: 899-906, 2005
11. McAlister FA, Stewart S, Ferrua S, McMurray JJ: Multidisciplinary strategies for the management of heart failure patients at high risk for admission: A systematic review of randomized trials. J Am Coll Cardiol 44: 810-819, 2004
12. Williams A: Intergenerational equity: an exploration of the 'fair innings' argument. Health Econ 6: 117-132, 1997
13. O'Hare AM, Kaufman JS, Covinsky KE, Landefeld CS, McFarland LV, Larson EB: Current guidelines for using angiotensin converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: Is the evidence base relevant to older adults? Ann Intern Med 150: 717-724, 2009
14. Campbell KH, O'Hare AM: Kidney disease in the elderly: Update on recent literature. Curr Opin Nephrol Hypertens 17: 298-303, 2008
15. Bakris GL, Weir MR: Angiotensin-converting enzyme inhibitor- associated elevations in serum creatinine: Is this a cause for concern? Arch Intern Med 160: 685-693, 2000
16. Molzahn AE, Hibbert MP, Gaudet D, Starzomski R, Barrett B, Morgan J: Managing chronic kidney disease in a nurse-run, physician-monitored clinic: The CanPREVENT experience. Can J Nurs Res 40: 96-112, 2008
17. Johnson ES, Thorp ML, Platt RW, Smith DH: Predicting the risk of dialysis and transplant among patients with CKD: A retrospective cohort study. Am J Kidney Dis 52: 653-660, 2008
18. Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS: A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305: 1553-1559, 2011
19. Briggs A, Mihaylova B, Sculpher M, Hall A, Wolstenholme J, Simoons M, Deckers J, Ferrari R, Remme WJ, Bertrand M, Fox K: Cost effectiveness of perindopril in reducing cardiovascular events in patients with stable coronary artery disease using data from the EUROPA study. Heart 93: 1081-1086, 2007
20. Smith DH, Raebel MA, Chan KA, Johnson ES, Petrik AF, Weiss JR, Yang X, Feldstein A: An economic evaluation of a laboratory monitoring program for renin-angiotensin system agents. Med Decis Making 31: 315-324, 2011